Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eucomed's Profile 2003 industry data now available:

This article was originally published in Clinica

Executive Summary

Europe's largest medical device industry association, Eucomed, has now finalised its Industry Profile 2003 and invited orders for the 75-page illustrated book. This Profile will be in much demand since, as the European Commission openly admits, there is a dearth of accurate data in this area. The report, which will officially be released at Eucomed's AGM in Cannes next week, is split into six main chapters. These are as follows: what is the medical technology industry; the medical technology market place (including expenditure on technology, market figures and import and export figures); healthcare priorities (including human tissues, diabetes and cancer); medical technology and EU legislation; international initiatives; and challenges and opportunities ahead.

You may also be interested in...

COVID-19 Vaccine 'Brexit Bonus' A Myth

The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.

Warning Letter Close-Outs – November 2020

The US Food and Drug Administration posted two device-related closeout letters in November.

Jazz And PharmaMar’s Zepzelca Hits Buffers In ATLANTIS Study

Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts